Company:  NOVUS THERAPEUTICS, INC. (NVUS)
Form Type:  SC 13G
Filing Date:  3/13/2018 
CIK:  0001404281 
Address:  19900 MACARTHUR BLVD.
SUITE 550
 
City, State, Zip:  IRVINE, California 92612 
Telephone:  949-238-8090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.79  
Change: 
-0.2115 (-7.05%)  
Trade Time: 
02:11 PM EST  
Market Cap: 
$26.27M
Trade NVUS now with 

© 2018  
Description of Business
Novus Therapeutics is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (ENT). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. The company's lead product (OP-02) is a surfactant-based, combination drug product being developed as a potential first-in-class treatment option for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). Globally, OM affects more than 700 million adults and children every year. OM is a common disorder seen in pediatric practice, and in the United States is the most frequent reason children are prescribed antibiotics and undergo surgery. Novus also has a foam-based drug delivery technology (OP-01), which may be developed in the future to deliver drugs into the ear, nasal, and sinus cavities.
Register and access this filing in:     
  FORM SC 13G